UnitedHealth Group Given New $99.00 Price Target at Barclays (UNH)
Equities research analysts at Barclays upped their price objective on shares of UnitedHealth Group (NYSE:UNH) from $84.00 to $99.00 in a research note issued to investors on Friday. Barclays’ price target suggests a potential upside of 16.32% from the stock’s previous close.
UnitedHealth Group (NYSE:UNH) opened at 85.11 on Friday. UnitedHealth Group has a 1-year low of $66.72 and a 1-year high of $87.24. The stock has a 50-day moving average of $81.14 and a 200-day moving average of $77.49. The company has a market cap of $83.396 billion and a P/E ratio of 15.62.
UnitedHealth Group (NYSE:UNH) last released its earnings data on Thursday, July 17th. The company reported $1.42 EPS for the quarter, beating the Thomson Reuters consensus estimate of $1.26 by $0.16. The company had revenue of $32.60 billion for the quarter, compared to the consensus estimate of $32.01 billion. During the same quarter in the prior year, the company posted $1.40 earnings per share. The company’s quarterly revenue was up 7.1% on a year-over-year basis. Analysts expect that UnitedHealth Group will post $5.54 EPS for the current fiscal year.
UNH has been the subject of a number of other recent research reports. Analysts at FBR Capital Markets raised their price target on shares of UnitedHealth Group from $85.00 to $95.00 in a research note on Thursday. They now have an “outperform” rating on the stock. Separately, analysts at Deutsche Bank reiterated a “buy” rating on shares of UnitedHealth Group in a research note on Wednesday. They now have a $92.00 price target on the stock, up previously from $88.00. Finally, analysts at Cowen and Company raised their price target on shares of UnitedHealth Group from $85.00 to $91.00 in a research note on Tuesday. Two research analysts have rated the stock with a sell rating, six have assigned a hold rating, ten have given a buy rating and one has issued a strong buy rating to the company’s stock. The stock has a consensus rating of “Buy” and a consensus target price of $83.74.
UnitedHealth Group Incorporated (NYSE:UNH) diversified health and well-being company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.